2012
DOI: 10.1097/mpa.0b013e31823cd3ef
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Treatment With Ethyl Pyruvate Attenuates the Severity of Liver Injury in Rats With Severe Acute Pancreatitis

Abstract: Our results demonstrate that EP might play a therapeutic role in liver inflammation in this SAP model, and these beneficial effects of EP are because of the modulation of high-mobility group box 1 and other inflammatory cytokine responses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(26 citation statements)
references
References 54 publications
0
26
0
Order By: Relevance
“…In patients and animals with AP, serum levels of HMGB1 are significantly elevated and positively correlate with the severity of this disease (Kocsis et al, 2009; Yasuda et al, 2007; Yasuda et al, 2006). Importantly, inhibiting the release or cytokine activity of HMGB1 (e.g., HMGB1 neutralizing antibody, ethyl pyruvate, danaparoid sodium, cisplatin, A box, antithrombin III, and pyrrolidine dithiocarbamate) confers protection against experimental AP (Cheng et al, 2007; Hagiwara et al, 2009g; Jo et al, 2013; Luan et al, 2013a; Luan et al, 2012; Luan et al, 2013b; Sawa et al, 2006; Weng et al, 2012; Yan et al, 2012a; Yang et al, 2009b; Yang et al, 2008; Yuan et al, 2009; Zhang et al, 2010). However, intracellular HMGB1 in the pancreas protects against acute pancreatitis (Kang et al, 2013b).…”
Section: Hmgb1 and Diseasementioning
confidence: 99%
“…In patients and animals with AP, serum levels of HMGB1 are significantly elevated and positively correlate with the severity of this disease (Kocsis et al, 2009; Yasuda et al, 2007; Yasuda et al, 2006). Importantly, inhibiting the release or cytokine activity of HMGB1 (e.g., HMGB1 neutralizing antibody, ethyl pyruvate, danaparoid sodium, cisplatin, A box, antithrombin III, and pyrrolidine dithiocarbamate) confers protection against experimental AP (Cheng et al, 2007; Hagiwara et al, 2009g; Jo et al, 2013; Luan et al, 2013a; Luan et al, 2012; Luan et al, 2013b; Sawa et al, 2006; Weng et al, 2012; Yan et al, 2012a; Yang et al, 2009b; Yang et al, 2008; Yuan et al, 2009; Zhang et al, 2010). However, intracellular HMGB1 in the pancreas protects against acute pancreatitis (Kang et al, 2013b).…”
Section: Hmgb1 and Diseasementioning
confidence: 99%
“…Concerning the lungs, EtP has been shown to protect against ventilation-induced neutrophil infiltration and the accompanying deleterious oxidative stress (25). Hepatic injury in animals with severe acute pancreatitis, but also sepsisor hemorrhage-induced organ injuries in vivo, were prevented by EtP (26)(27)(28)(29). Collectively, these results suggest that due to its stability, lack of adverse effects, wide therapeutic window and apparently no signs of intoxication, EtP will be useful in a clinical setting for the treatment of acute inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…The anti-inflammatory effects of pyruvate have been implicated in several pathologies, such as severe acute pancreatitis, 22 liver injury in diabetic rats, 23 cataracts 24 down-regulation of oxidative stress, albuminuria and glomerular injury in animal models of nephropathy. 2,25 The anti-inflammatory activities of pyruvate have been associated with i) the inhibition of cellular adhesion to the endothelium, 3 ii) the inhibition of NADPH-oxidase in kidney lesion, 2 iii) the association between the up-regulation of HO-1 and the inhibition of nitric oxide synthase expression associated with high-mobility group box 1 (HMGB-1) release in RAW 264.7 cells, 7 and iv) the down-regulation of oxidative stress and HMGB-1 expression during lung injury in C57BL/mice.…”
Section: Discussionmentioning
confidence: 99%